BeStock  
Stocks › Biotechnology › AAPG

Ascentage Pharma AAPG

US equityMarket cap rank #3080Biotechnology
$11.97 −$0.47 (-3.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $11.97 0.00%
Open$12.26
Prev close$12.44
Day range$11.97 – $12.26
Volume5,039
Market cap$1.12B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership26.2%+0.56 pts vs. prior quarter
Institutions holding59+0 vs. prior quarter
Insider trades (recent)6 buys / 0 sellsNet buying
Short interest0.01% of floatDays to cover 1.0 · as of 30 Oct 2026
Short-sale volume share15.8%5-day average of daily volume

Short-sale volume as % of daily volume

-5%18%40%63%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$33.7K (3 inflow days, 17 outflow days).

Net flow by order size, last 20 sessions

+$39.1KSuper−$5,443Big+$88.8KMid−$15.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 23.7% of shares outstanding.

Largest holders

  • Takeda Pharmaceuticals International AG6.61%
  • Dajun Yang6.32%
  • HealthQuest Pharma Limited3.83%
  • Ming Guo3.60%
  • Vanguard Capital Management, LLC3.35%
  • China Universal Asset Management Company Ltd.2.96%
  • Shaomeng Wang2.73%
  • BlackRock1.46%

By investor type

  • Mutual Fund14.43%
  • Individual/Insider12.90%
  • Private Company10.44%
  • Sovereign Wealth Fund1.30%
  • Hedge Fund0.05%
  • Public Company0.00%
  • Family Office/Trust0.00%

Reported short interest has held roughly steady near 0.01% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Ping An of China Asset Management (Hong Kong) Company Limited Mutual Fund 2026/Q3 +1,407 0.0%
China Asset Management Co., Ltd. Mutual Fund 2026/Q3 +28,510 0.5%
State Street Global Advisors Mutual Fund 2026/Q3 +49,000 0.2%
China Asset Management (Hong Kong) Limited Mutual Fund 2026/Q3 +209,550 0.2%
BlackRock Mutual Fund 2026/Q3 +16,950 1.5%
China Asset Management Co., Ltd. Mutual Fund 2026/Q3 +56,585 0.5%
CSOP Asset Management Limited Mutual Fund 2026/Q3 +1,569 0.1%
HSBC Global Asset Management (UK) Limited Mutual Fund 2026/Q3 +5,048 0.0%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +217,150 3.4%
China Asset Management (Hong Kong) Limited Mutual Fund 2026/Q3 +208,900 0.2%
State Street Global Advisors Mutual Fund 2026/Q3 +49,900 0.2%
BlackRock Mutual Fund 2026/Q3 +15,625 1.5%
Arax Advisory Partners, LLC Mutual Fund 2026/Q3 +1,230 0.0%
China Asset Management Co., Ltd. Mutual Fund 2026/Q3 +5,280 0.5%
CSOP Asset Management Limited Mutual Fund 2026/Q3 +234 0.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
20 May 2026 Yifan Zhai Chief Medical Officer Derivative Exercise and Retained +92,746 – 405,280
20 May 2026 Dajun Yang Chairperson & CEO Derivative Exercise and Retained +95,575 – 23,247,700
19 May 2026 Yifan Zhai Chief Medical Officer Other Derivative Acquisition +616,546 $8.12 298,194
19 May 2026 Yifan Zhai Chief Medical Officer Other Derivative Acquisition +804,880 – 298,195
19 May 2026 Dajun Yang Chairperson & CEO Other Derivative Acquisition +616,546 $8.12 103,364
19 May 2026 Dajun Yang Chairperson & CEO Other Derivative Acquisition +804,880 – 92,746
17 Mar 2026 Jiuyun Yu Independent Non-Executive Director Initial Statement of Beneficial +0 – 27,965
17 Mar 2026 Marc Lippman Independent Non-Executive Director Initial Statement of Beneficial +0 – 21,174
17 Mar 2026 Marina S. Bozilenko Independent Non-Executive Director Initial Statement of Beneficial +0 – 45,930
17 Mar 2026 David Sidransky Lead Independent Non-Executive Director Initial Statement of Beneficial +0 – 10,641
17 Mar 2026 Thomas Knapp General Counsel Initial Statement of Beneficial +0 – 38,938
17 Mar 2026 Shaomeng Wang Co-Founder, Chief Scientific Advisor & Non-Executive Director Initial Statement of Beneficial +0 – 27,965
17 Mar 2026 Yifan Zhai Chief Medical Officer Initial Statement of Beneficial +0 – 103,364
17 Mar 2026 Changqing Ye Independent Non-Executive Director Initial Statement of Beneficial +0 – 8,964
17 Mar 2026 Dazhong Lu Independent Non-Executive Director Initial Statement of Beneficial +0 – 41,457
17 Mar 2026 HealthQuest Pharma Limited Initial Statement of Beneficial +0 – 14,089,111
17 Mar 2026 Dajun Yang Chairperson & CEO Initial Statement of Beneficial +0 – 143,463
17 Mar 2026 Wei Ren Independent Non-Executive Director Initial Statement of Beneficial +0 – 28,850
17 Mar 2026 Jin Cao Head of Finance Initial Statement of Beneficial +0 – 12,883

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 9,125 0.0% 1.0
15 Oct 2026 18,161 0.0% 2.6
30 Sep 2026 9,250 0.0% 1.5
15 Sep 2026 19,861 0.0% 3.1
31 Aug 2026 15,260 0.0% 1.8
14 Aug 2026 14,177 0.0% 2.9

Discussion

No comments yet — be the first to weigh in on AAPG.

Sign in to join the discussion.

Scroll to Top